Global Outpatient Infusion Therapy Services Market

MARKET SCOPE:

The global Outpatient Infusion Therapy Services market is projected to grow significantly, registering a CAGR of 11.1% during the forecast period (2024 – 2032).

Outpatient Infusion Therapy Services pertain to medical procedures where medications, fluids, or blood products are administered through a needle or catheter. These services are delivered in an outpatient environment, eliminating the need for patients to be hospitalized during their treatment. Instead, individuals can undergo infusion therapy at specialized clinics, infusion centers, or other outpatient facilities. The market for Outpatient Infusion Therapy Services encompasses the comprehensive landscape of providing infusion therapy beyond the confines of a hospital. This market includes the infrastructure, healthcare professionals, equipment, and medications essential for the administration of outpatient infusion therapy. Infusion therapy finds widespread application in treating various medical conditions such as cancer, autoimmune disorders, infections, and specific chronic diseases.

MARKET OVERVIEW:

Driver: Growing occurrence of chronic diseases over the world is driving the market growth.

The surge in the prevalence of chronic diseases, encompassing cancer and autoimmune disorders, stands as a pivotal catalyst propelling the escalating demand for outpatient infusion therapy. This burgeoning trend is shaped by various elements, necessitating an exploration of the confluence of demographic changes, advancements in healthcare technology, and the dynamic landscape of chronic disease management. With the global population aging, there is a noticeable uptick in the occurrence of chronic diseases, particularly those such as cancer and autoimmune disorders that tend to manifest more frequently with advancing age. This demographic shift contributes significantly to the heightened demand for medical services and treatments. Infusion therapy, a vital component in managing chronic conditions, becomes indispensable for an expanding cohort of individuals seeking effective and personalized healthcare solutions. The global rise in the incidence of cancer and autoimmune disorders can be attributed to diverse factors, including environmental shifts, lifestyle choices, and genetic predispositions. This upsurge underscores the imperative for long-term and specialized treatment plans to address these complex conditions. Within these comprehensive treatment strategies, infusion therapy emerges as a prevalent method for administering medications, immunotherapies, and targeted treatments tailored to the specific needs of patients combating cancer and autoimmune disorders.

Opportunities: Government Initiatives and technological advancements the technique and instruments of infusion therapy are expected to pave the way for market growth in the upcoming years.

Progress in infusion therapy techniques and devices is a pivotal driver of market expansion, delivering heightened convenience and safety for patients undergoing outpatient infusion therapy. The relentless march of technology has spawned innovative devices, including smart pumps and wearable infusion devices, enhancing overall efficiency and the patient experience in outpatient settings. Smart pumps, representing technologically advanced infusion devices, boast features like programmable drug delivery, dose calculations, and real-time monitoring. These pumps empower healthcare providers with enhanced control over medication administration, ensuring precision and accuracy in dosing. Consequently, this contributes significantly to the improvement of patient safety and treatment efficacy.

Wearable infusion devices, crafted to be worn by patients, introduce a new dimension of mobility and flexibility during treatment. Discreet, portable, and often equipped with intelligent technology to monitor and regulate the infusion process, these devices enable patients to seamlessly integrate treatment into their daily activities. This approach promotes a more comfortable and less disruptive experience for individuals undergoing outpatient infusion therapy. The progress in infusion therapy devices is inherently centered on prioritizing patient convenience and engagement. The evolution of user-friendly interfaces and wireless connectivity empowers patients with greater control and comprehension of their treatment plans. Additionally, the incorporation of remote monitoring capabilities in these devices proves instrumental for healthcare professionals. It enables them to track patients' progress and intervene promptly, even when the patient is not physically present in the healthcare facility. This not only streamlines the treatment process but also reinforces the patient-centric nature of modern outpatient infusion therapy.

COVID IMPACT:

The outpatient oncology infusion market experienced a moderate influence from the COVID-19 pandemic. During the pandemic, the global identification of new cancer cases has shown a decline and delay. Cancer patients have faced setbacks in their treatment schedules, including delays in clinic follow-up appointments and various therapies such as infusion treatments, surgical tumor removal, and radiation therapy. Nevertheless, with the easing of restrictions in 2021, there was an uptick in the treatment of breast, urinary, and gynecologic tumors, ranging from 3% to 73%.

SEGMENTATION ANALYSIS:

The infusion pump segment is anticipated to grow significantly during the forecast period.

The infusion pump segment secured the highest market share, primarily driven by the escalating instances of cancer globally and the increasing utilization of infusion pumps for cancer therapy. For instance, according to the World Health Organization (WHO), cancer was the second-leading cause of global mortality in 2018, accounting for approximately 9.6 million deaths. Moreover, the continuous administration of chemotherapy, essential for cancer patients, is efficiently facilitated through the deployment of infusion pumps. Infusion pumps play a pivotal role in delivering fluids, including medications, antibiotics, and nutrients, with precision and consistency into a patient's body. Notably, cancer patients necessitate the consistent delivery of chemotherapy, a requirement aptly met by the utilization of infusion pumps. Various types of infusion pumps, such as ambulatory chemotherapy pumps and implantable pumps, prove instrumental in the management of cancer across diverse healthcare settings, including hospitals, outpatient care centers, and home care settings. The inherent advantages associated with these products, including precise fluid delivery and the ability to manage cancer treatment conveniently in different healthcare settings, are poised to drive both the infusion pump segment and the broader outpatient oncology infusion market during the forecast period.

The cancer segment is anticipated to grow significantly during the forecast period.

Factors such as the increasing incidence of lung cancer, a growing elderly population, and evolving lifestyles characterized by high smoking rates contribute to a substantial population afflicted by lung carcinoma. This, in turn, drives the demand for outpatient oncology infusion therapy, thereby fostering market growth. To illustrate, the American Cancer Society's 2022 data reveals that lung cancer stands as the predominant cause of mortality in both men and women, accounting for more than 25% of all cancer-related deaths. Additionally, the rising introduction of targeted therapies for lung cancer treatment is set to propel the outpatient oncology infusion market in the analysis timeframe. For example, in September 2018, Pfizer Inc. obtained U.S. FDA approval for VIZIMPRO (dacomitinib) for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer.

REGIONAL ANALYSIS:

The North American region is set to witness significant growth during the forecast period.

The North America outpatient infusion therapy services sector held a significant market share due to several factors, including favorable government initiatives, a growing number of cancer patients, and an increasing geriatric population, among other considerations. For instance, according to the Population Reference Bureau, the projected doubling of Americans aged 65 and above by 2060, from 52 million in 2018, underscores the rising demographic shift towards an older population. The prevalence of chronic diseases, particularly cancer, has also played a pivotal role in expanding the market. According to the National Cancer Institute, approximately 1,806,590 cancer cases were identified in the U.S. in 2020 alone, contributing to the overall growth of the outpatient infusion therapy services industry in the region. Moreover, the North American market benefits from the continuous approval of new products. For instance, in May 2021, Amgen obtained approval from the U.S. Food and Drug Administration (FDA) for LUMAKRAS (sotorasib), designed for treating adult patients with KRAS G12C-mutated metastatic non-small cell lung cancer (NSCLC). This regulatory approval not only facilitated the company in boosting product sales but also strengthened its position within the North American outpatient oncology infusion industry.

COMPETITIVE ANALYSIS

The global Outpatient Infusion Therapy Services market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.

ICU Medical

• In January 2022, ICU Medical successfully acquired Smiths Medical from Smiths Group plc. The Smiths Medical segment comprised syringe and ambulatory infusion devices, vascular access, and vital care products. Its primary focus was on delivering high-quality, innovative, and value-added services. Implementing such strategic approaches will contribute significantly to enhancing the company's market position.

Option Care Health

Coram CVS

UnitedHealth Group

HCA Healthcare

McLaren

CHI Health

Accredo Health

PharMerica

Cleveland Clinic

SCOPE OF THE REPORT

By Type

• Cancer
• Chronic Disease

By Product

• Infusion Pumps
• Infusion Set
• Accessories

By Application

• Hospital
• Clinic

By Region

• North America (the United States & Canada)
• Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
• Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa, and Latin America)

KEY REASONS TO PURCHASE THIS REPORT

It provides a technological development map over time to understand the industry’s growth rate and indicates how the Outpatient Infusion Therapy Services market is evolving.

The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Outpatient Infusion Therapy Services submarket will be the main driver of the overall market from 2024 to 2032.

It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.

It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032. Show more